Synthesis and reactions of 2,4-disubstituted benzo[b]furano-, benzo[b]thieno- and indolo[3,2-d]-1,3-oxazinium salts
作者:S. V. Tolkunov、V. N. Voshchula、E. A. Zemskaya、V. I. Dulenko
DOI:10.1007/bf00476992
日期:1990.11
TOLKUNOV, S. V.;VOSHCHULA, V. N.;ZEMSKAYA, E. A.;DULENKO, V. I., XIMIYA GETEROTSIKL. SOED.,(1990) N1, S. 1569-1571
作者:TOLKUNOV, S. V.、VOSHCHULA, V. N.、ZEMSKAYA, E. A.、DULENKO, V. I.
DOI:——
日期:——
[EN] INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS<br/>[FR] INHIBITEURS DE L'ACTIVITÉ CGAS UTILISÉS À TITRE D'AGENTS THÉRAPEUTIQUES
申请人:BELLBROOK LABS
公开号:WO2020142729A1
公开(公告)日:2020-07-09
This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.